The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The investigators wish to study the effect of retaining potassium. The participants have
essential hypertension. The test substances are Amiloride, Spironolactone and placebo. The
participants will ingest tablets for 28 days before being examined. We will perform a 24
hours urine collection, 24-hours bloodpressure measurement, blood and urine samples and we
also examine the patient using a SphygmoCor.